Risankizumab in Severe Asthma: A Phase IIa, Placebo-Controlled Study

Christopher E Brightling, Parameswaran Nair, David J. Cousins, Renaud Louis, Dave Singh

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Risankizumab in Severe Asthma: A Phase IIa, Placebo-Controlled Study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology